Breaking News Instant updates and real-time market news.

FB

Facebook

$172.23

0.99 (0.58%)

, AET

Aetna

$161.28

-0.01 (-0.01%)

08:55
10/07/17
10/07
08:55
10/07/17
08:55

Week in review: How Trump's policies moved stocks

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly: 1. HEALTH CARE REFORM: While noting the resignation of Health Secretary Tom Price, Bernstein analyst Lance Wilkes said on Monday that he does not anticipate an Affordable Care Act fix or repeal before the 2018 election. The analyst expects tax reform will "suck the oxygen out of the room" until close to the election. A fix for 2019 is possible, but faces the headwind of the 2018 election campaign, he contended, adding that he believes CSR funding could be included in a trade for the upcoming budget and the Health Insurance Fee could be suspended as part of tax reform, but both are not highly likely at this point. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG). 2. TAX REFORM: On Thursday, the House passed a $4.1T budget, the first concrete step toward tax reform. The vote in full Senate is slated for the week of October 16. By passing a budget resolution through both chambers, Republicans would trigger a legislative process known as reconciliation, during which they could pass a sweeping tax reform bill with a simple majority of 51 votes in the Senate. According to a report by CNBC, however, it is still far from certain that Republicans will be able to find enough common ground to actually pass the tax reform package, with disagreement already emerging over how much to cut certain tax rates and whether it would be revenue-neutral. 3. INSURERS: Shares of the insurers of Puerto Rico's bonds, including MBIA (MBI), Assured Guaranty (AGO), and Ambac Financial Group (AMBC) were under pressure on Monday after President Donald Trump said that his administration would wipe out Puerto Rico's debt to hasten the recovery from the damage that was left by recent hurricanes. During an interview with Fox News, President Trump said, "We have to look at their whole debt structure... You know, they owe a lot of money to your friends on Wall Street, and we're going to have to wipe that out." 4. RUSSIAN PROBE: Facebook (FB) CEO Mark Zuckerberg and COO Sheryl Sandberg not likely to testify before Congress early next month, when the company will face scrutiny over how Russia-based groups used the social network giant's ad-buying technology to influence the 2016 U.S. presidential election, according to a report by CNBC. Meanwhile, Bloomberg said on Wednesday that U.S. lawmakers are looking into Google's (GOOG, GOOGL) YouTube and Gmail services as part of their investigation into how Russian-linked operatives used social media during the 2016 election. 5. FUEL REQUIREMENTS: According to Reuters, citing a letter made public by Senator Amy Klobuchar's office, 38 senators have asked the Environmental Protection Agency to abandon plans to lower biofuels requirements for oil refiners in 2018. Publicly traded companies in the space include Delek US (DK), HollyFrontier (HFC), Marathon Petroleum (MPC), Phillips 66 (PSX), Tesoro (TSO), Valero (VLO), Western Refining (WNR), Green Plains (GPRE), Pacific Ethanol (PEIX), Renewable Energy Group (REGI) and Darling Ingredients (DAR). 6. 'FAKE NEWS': Earlier this week, Secretary of State Rex Tillerson highlighted the "team" accomplishments of President Trump's foreign policy staff in a press conference after an NBC News report that claimed he called the President a "moron" this summer. Tillerson said he never considered leaving his post and that Vice President Pence never had to talk him into staying, as NBC News claimed in its report. After Tillerson's press conference, President Trump tweeted, "The @NBCNews story has just been totally refuted by Sec. Tillerson and @VP Pence. It is #FakeNews. They should issue an apology to AMERICA!" NBC is a unit of Comcast (CMCSA). 7. NATIONAL MANUFACTURING DAY: On Friday, President Donald Trump met with members of the National Association of Manufacturers and representatives of the industry. Trump also signed a proclamation honoring National Manufacturing Day, saying his administration is helping "compete and win on the world stage." "Week in Review" is The Fly's weekly recap of its recurring series of "Trump Effect" exclusive stories.

FB

Facebook

$172.23

0.99 (0.58%)

AET

Aetna

$161.28

-0.01 (-0.01%)

ANTM

Anthem

$193.22

0.3 (0.16%)

CNC

Centene

$98.01

0.66 (0.68%)

CI

Cigna

$190.95

0.27 (0.14%)

HNT

Health Net

HUM

Humana

$246.90

1.54 (0.63%)

MOH

Molina Healthcare

$67.86

0.49 (0.73%)

UNH

UnitedHealth

$198.06

0.16 (0.08%)

WCG

WellCare

$174.04

1.94 (1.13%)

MBI

MBIA

$7.65

0.01 (0.13%)

AGO

Assured Guaranty

$37.54

-0.19 (-0.50%)

AMBC

Ambac Financial

$16.92

0.32 (1.93%)

DK

Delek US

$26.12

-0.35 (-1.32%)

HFC

HollyFrontier

$35.42

-0.43 (-1.20%)

MPC

Marathon Petroleum

$56.02

-0.23 (-0.41%)

PSX

Phillips 66

$92.82

-0.51 (-0.55%)

TSO

Tesoro

VLO

Valero

$77.23

-0.04 (-0.05%)

WNR

Western Refining

GPRE

Green Plains

$20.05

-0.5 (-2.43%)

PEIX

Pacific Ethanol

$5.43

-0.275 (-4.82%)

REGI

Renewable Energy

$11.60

-0.5 (-4.13%)

DAR

Darling Ingredients

$16.38

-1.51 (-8.44%)

CMCSA

Comcast

$38.01

-0.34 (-0.89%)

  • 08

    Oct

  • 17

    Oct

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

  • 16

    Nov

FB Facebook
$172.23

0.99 (0.58%)

09/28/17
DBAB
09/28/17
NO CHANGE
Target $220
DBAB
Buy
Deutsche sees upside to Facebook estimates, boosts target to $220
Deutsche Bank analyst Lloyd Walmsley raised his Q3 and 2018 estimates for Facebook citing "increasing signs of strength." Conversations in the advertising industry continue to point towards "strong" same-client budget growth in Q3 and a longer term willingness to "lean into" new inventory on Facebook, Walmsley tells investors in a research note. He increased his ad revenue growth rate excluding currency for Facebook to 42% from 39% in Q3 and to 32% from 30% in 2018. The analyst believes Facebook has the most upside to estimates over the next 6-12 months and is his favorite name among the large cap Internet space. Walmsley upped his price target for the shares to $220 from $215 and keeps a Buy rating on the name. Facebook closed yesterday up $3.47 to $167.68.
10/02/17
MSCO
10/02/17
NO CHANGE
Target $40
MSCO
Equal Weight
Morgan Stanley raises price targets on Facebook, Priceline, Yelp
Morgan Stanley analyst Brian Nowak issued a note recapping his views on which U.S. Internet names are set to outperform the rest of this year and into next year, saying he is positive on Facebook (FB), Google (GOOGL) and Priceline (PCLN) among large caps. He raised his price target on Facebook to $195 from $190 and increased his price target on Priceline to $2,100 from $2,050. Nowak also raised his price target on Yelp (YELP) to $40 from $26, saying he believes near-term estimates on the Street are too low. However, he keeps an Equal Weight rating on Yelp shares, citing the recent slowdown in local account growth and worries about churn.
10/02/17
BWSF
10/02/17
NO CHANGE
BWSF
Sell
BWS Financial sees Applied Optoelectronics sales to Amazon softening further
BWS Financial analyst Hamed Khorsand said he believes Applied Optoelectronics (AAOI) sales to Amazon (AMZN) have softened even more as the company moves away from 40G. He also thinks Intel's (INTC) start of shipments of a competing CWDM4 transceivers poses a threat to 100G revenue Applied has been generating from Facebook (FB). Khorsand keeps his Sell rating on Applied Optoelectronics shares.
10/05/17
NEED
10/05/17
NO CHANGE
NEED
Checks on Facebook positive, says Needham
After conducting checks, Needham analyst Laura Martin says that the company "is hitting on all cylinders," with Instagram and Messenger causing her to raise her ad supply and targeting estimates for the company. Martin adds that the company's user growth is exceeding her prior expectations. The analyst raised her estimates for the company and keeps a $185 price target and a Buy rating on the shares.
AET Aetna
$161.28

-0.01 (-0.01%)

07/14/17
PIPR
07/14/17
NO CHANGE
Target $18
PIPR
Overweight
Piper views updated Aetna policy as disappointing for Natera
Piper Jaffray analyst William Quirk views Aetna's (AET) updated non-invasive prenatal testing medical policy, where it decided to continue covering the test only in high risk, as "disappointing." Upside for Natera (NTRA) in the second half of 2017 now falls on Medicaid and microdeletion reimbursement progress, and less so commercial payers flipping to cover average risk, Quick tells investors in a research note. He keeps an Overweight rating on Natera shares with an $18 price target.
10/06/17
LEER
10/06/17
NO CHANGE
LEER
Leerink convinced Amazon entering drug distribution within two years
After calls with pharmacy benefit managers and retail pharmacy specialists, Leerink analyst Ana Gupte says she's convinced that Amazon.com (AMZN) "will almost certainly" enter the drug distribution value chain within two years, evolving into a more disruptive offering over time. Amazon's move is most threatening for retail pharmacies Walgreens Boots Alliance (WAB), CVS Health (CVS) and Wal-Mart (WMT), Gupte tells investors in a research note. The analyst calls Amazon both an opportunity and threat for Express Scripts (ESRX) and views UnitedHealth (UNH) and Humana (HUM) as "largely buffered." Gupte's conversations with specialists indicate Amazon is hiring relevant talent and is in active discussions with mid-market pharmacy benefit managers and possibly even with large players such as Prime Therapeutics. It is believed Amazon will start by capturing share in both the cash paying and third party mail order and possibly specialty pharmacy segments, Gupte notes. She expects Anthem (ANTM), Aetna (AET) and Cigna (CI) will likely to contemplate Amazon's entry in their upcoming PBM contract decisions.
09/12/17
ARGS
09/12/17
NO CHANGE
ARGS
Aetna price target raised to $185 from $165 at Argus
Argus analyst David Toung believes that Aetna reported "strong" Q2 results. The analyst remains upbeat on the company's 2H17 outlook and keeps a Buy rating on the shares.
10/02/17
BERN
10/02/17
NO CHANGE
BERN
Bernstein does not anticipate ACA fix/repeal before 2018 election
While noting the resignation of Health Secretary Tom Price, Bernstein analyst Lance Wilkes says he does not anticipate an Affordable Care act fix or ACA repeal before the 2018 election. The analyst expects tax reform will "suck the oxygen out of the room" until close to the election. A fix for 2019 is possible, but faces the headwind of the 2018 election campaign, he contends, adding that he believes CSR funding could be included in a trade for the upcoming budget and the Health Insurance Fee could be suspended as part of tax reform, but both are not highly likely at this point. Publicly traded companies in the space include Aetna (AET), Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
ANTM Anthem
$193.22

0.3 (0.16%)

09/19/17
RBCM
09/19/17
INITIATION
RBCM
Sector Perform
Express Scripts initiated with a Sector Perform at RBC Capital
RBC Capital analyst George Hill started coverage of Express Scripts (ESRX) with a $68 price target and a Sector Perform rating. The analyst says that the company "faces an uncertain future" in the wake of the loss of its deal with Anthem ( ANTM), as he believes that it will have difficulty generating operating profit growth without Anthem.
07/12/17
FBCO
07/12/17
INITIATION
Target $195
FBCO
Neutral
Anthem initiated with a Neutral at Credit Suisse
Credit Suisse analyst Scott Fidel started Anthem with a Neutral rating and $195 price target. The company has produced slower earnings growth over the past decade relative to Managed Care peers and its returns on capital are also "sub-par relative to comps," the analyst contends. He believes Anthem is "entering a new chapter" following the failed Cigna (CI) acquisition and "uncertain future" of the Affordable Care Act's exchanges and Medicaid expansion.
CNC Centene
$98.01

0.66 (0.68%)

09/13/17
LEER
09/13/17
NO CHANGE
Target $90
LEER
Market Perform
Centene price target raised to $90 from $78 at Leerink
Leerink analyst Ana Gupte raised her price target for Centene to $90 from $78 as she is positive on it after the announcement of the Fidelis AMC acquisition. The analyst reiterates a Market Perform rating on the shares.
09/29/17
OPCO
09/29/17
NO CHANGE
Target $105
OPCO
Outperform
Centene price target raised to $105 from $95 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Centene to $105 and would continue to be a buyer of the stock. After attending meetings with management, the analyst believes the company "remains attractively positioned," especially in light of the failed efforts to repeal the Affordable Care Act. He sees reduced risk around repeal and keeps an Outperform rating on Centene.
09/13/17
CANT
09/13/17
NO CHANGE
Target $107
CANT
Overweight
Centene price target raised to $107 from $100 at Cantor
Cantor Fitzgerald analyst Steven Halper raised his price target for Centene shares to $107 following the company's acquisition of Fidelis Care. The analyst views the acquisition positively, both from a strategic and financial perspective. He keeps an Overweight rating on Centene.
CI Cigna
$190.95

0.27 (0.14%)

06/23/17
LEER
06/23/17
NO CHANGE
LEER
Outperform
Draft version of Senate healthcare bill better than expected, says Leerink
Leerink analyst Ana Gupte said she views the draft version of the Senate healthcare bill as better than expected, stating that stabilization of the Exchanges and risk stabilization is a direct positive for health insurers and indirect positive for facility operators. The Senate bill maintains the House bill's plan to repeal all "ObamaCare" industry fees and taxes, which is a positive for Managed Care and Medical Technology players, Gupte adds. She keeps Outperform ratings on Anthem (ANTM), UnitedHealth (UNH), Cigna (CI), Humana (HUM), WellCare (WCG), Molina Healthcare (MOH) and acute care hospital operators HCA Holdings (HCA), Tenet (THC) and LifePoint (LPNT).
HNT Health Net

11/09/16
BERN
11/09/16
NO CHANGE
BERN
Health insurers to see multiple catalysts from Trump presidency, says Bernstein
Bernstein analyst Lance Wilkes says that "repealing and replacing Obamacare will be Trump's primary focus." The analyst expects health insurers to benefit from from the repeal of ACA taxes and the elimination of requirements to spend a certain percentage of revenue on medical costs. Wilkes expects Anthem (ANTM) and Blue Cross/Blue Shield providers to benefit from the elimination of public exchanges and broad coverage requirements. Other health insurers include Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
06/23/17
JEFF
06/23/17
NO CHANGE
JEFF
Jefferies says healthcare rally 'appropriate' after 'toothless' AHCA rewrite
Jefferies analyst David Windley said the rally yesterday in healthcare stocks was appropriate given the "anemic" rewrite of the AHCA healthcare bill by Senate Republicans. The key changes are removal of "pay-for" taxes, a somewhat longer runway for Exchange cost-sharing reduction subsidies, and delayed Medicaid transition to per capita caps, he tells investors. Windley called Cigna (CI) "probably the safest MCO in this noise", adding that Humana (HUM) would benefit most from the proposed removal of the health insurer fee. Other publicly traded healthcare insurers include Aetna (AET), Anthem (ANTM), Centene (CNC), Health Net (HNT), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
HUM Humana
$246.90

1.54 (0.63%)

08/03/17
FBCO
08/03/17
NO CHANGE
Target $260
FBCO
Outperform
Humana price target raised to $260 from $250 at Credit Suisse
Credit Suisse analyst Scott Fidel raised his price target for Humana to $260 from $250 following quarterly results. The analyst reiterates an Outperform rating on the shares.
08/03/17
OPCO
08/03/17
NO CHANGE
Target $255
OPCO
Outperform
Humana price target raised to $255 from $236 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for Humana to $255 from $236 following "strong results" that were driven by outperformance in Medicare Advantage, and after the company raised 2017 EPS guidance. The analyst reiterates an Outperform rating on the shares.
MOH Molina Healthcare
$67.86

0.49 (0.73%)

09/21/17
MUFG
09/21/17
INITIATION
Target $70
MUFG
Neutral
Molina Healthcare initiated with a Neutral at MUFG
MUFG analyst Jason Twizell started Molina Healthcare with a Neutral rating and $70 price target.
08/17/17
08/17/17
UPGRADE
Target $68

Overweight
Molina Healthcare upgraded to Overweight from Underweight at Morgan Stanley
As previously reported, Morgan Stanley upgraded Molina Healthcare two notches to Overweight from Underweight and raised its price target to $68 from $65. Analyst Zack Sopcak sees a clear path to growth from a clear cost cutting plan and strategy, and favorable risk/reward following the 15% decline in shares since June. The analyst believes interim management's clear restructuring targets are achievable and limit share downside. Sopcak said Molina is on the "cusp" of being the next managed care organization to succeed on a turnaround after bottoming out in Q2.
08/17/17
PIPR
08/17/17
NO CHANGE
Target $70
PIPR
Overweight
Molina has sufficient cash without capital raise, says Piper Jaffray
Piper Jaffray analyst Sarah James believes concerns around Molina Healthcare's cash levels, which drove the stock down 5% in the last week, are overdone. After addressing the issue with management, James is "comfortable and confident" that Molina has sufficient cash to meet its needs and has excess reserves without needing an equity raise as feared by bears. The analyst views the shares as undervalued and keeps an Overweight rating on the name with a $70 price target.
UNH UnitedHealth
$198.06

0.16 (0.08%)

08/29/17
PIPR
08/29/17
NO CHANGE
Target $54.29
PIPR
Neutral
Piper says Advisory Board deal should be marginally accretive to UnitedHealth
Piper Jaffray analyst Sean Wieland said Advisory Board's (ABCO) deal to merge its healthcare business with United Healthcare's (UNH) OptumInsights should be marginally accretive to UnitedHealth and add to his confidence in his FY18 OptumInsights growth estimates. He keeps a Neutral rating on Advisory Board shares and raised his price target on the stock to $54.29 from $51 to reflect the combined estimated amount being paid to shareholders by Optum and Vista Equity, the buyers of Advisory's education business.
08/30/17
ADAM
08/30/17
DOWNGRADE
Target $54
ADAM
Hold
The Advisory Board downgraded to Hold from Buy at Canaccord
Canaccord analyst Richard Close downgraded The Advisory Board (ABCO) to Hold from Buy based on the announced transaction to split the company by selling the Healthcare business to UnitedHealth's (UNH) Optum unit and the Education Business to Vista Equity Partners. Close lowered his price target to $54.29 on Advisory Board shares.
WCG WellCare
$174.04

1.94 (1.13%)

08/25/17
CANT
08/25/17
INITIATION
Target $195
CANT
Overweight
WellCare coverage assumed with an Overweight at Cantor
Cantor analyst Steven Halper assumed coverage on WellCare with an Overweight and a $195 price target.
09/21/17
MUFG
09/21/17
INITIATION
Target $204
MUFG
Overweight
WellCare initiated with an Overweight at MUFG
MUFG analyst Jason Twizell started WellCare Health Plans with an Overweight rating and $204 price target.
08/25/17
08/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Walgreens Boots Alliance (WBA) initiated with a Buy and CVS Health (CVS) and Fred's (FRED) initiated with a Hold at Loop Capital. 2. Adobe (ADBE), Intuit (INTU), GoDaddy (GDDY) initiated with a Buy at Jefferies, while Mindbody (MB) was initiated with a Hold. 3. New Oriental Education (EDU), Bright Scholar (BEDU) and TAL Education (TAL) initiated with Overweight ratings at Morgan Stanley. 4. WellCare (WCG) coverage assumed with an Overweight at Cantor. 5. Dollar Tree (DLTR) and Dollar General (DG) reinstated with Buy ratings at BofA/Merrill. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MBI MBIA
$7.65

0.01 (0.13%)

01/30/17
MKMP
01/30/17
NO CHANGE
Target $15
MKMP
Buy
MBIA weakness a buying opportunity, says MKM Partners
MKM Partners analyst Harry Fong said MBIA shares are down 10% over the past several days likely to stories that Puerto Rico's electric utilities' restructuring agreement may need to be revised. Fong believes the restructuring will be completed as currently structured and would use the weakness in MBIA as a buying opportunity. The analyst rates MBIA a Buy with a $15 price target.
06/07/17
BTIG
06/07/17
NO CHANGE
BTIG
MBIA may be more likely to accept takeover offer, says BTIG
BTIG analyst Mark Palmer believes that S&P's decision to place the credit rating of MBIA's (MBI) National Public Finance Guarantee Corp.on credit watch negative could increase the chances of MBIA selling itself to Assured Guaranty (AGO). Plamer thinks that such a deal would be a "win-win" for MBIA and Assured Guaranty. He keeps Buy ratings on both stocks.
10/05/17
MKMP
10/05/17
NO CHANGE
MKMP
Bond insurer decline could be opportunity, says MKM Partners
After President Trump said all of Puerto Rico's debt would have to be wiped out, MKM PArtners analyst Harry Fong does not expect the debt to actually be wiped out. He believes that taking this step would violate the principles of contract law and could destroy the municipal bond market. The analyst adds that the bond insurers will not face liquidity issues if Puerto Rico's debt is wiped out. He believes that the decline in their stocks could prove to be a buying opportunity. He keeps Buy ratings on Assured Guaranty (AGO) and MBIA (MBI), and he maintains a Neutral rating on Ambac (AMBC).
AGO Assured Guaranty
$37.54

-0.19 (-0.50%)

11/29/16
UBSW
11/29/16
NO CHANGE
Target $40
UBSW
Buy
Assured Guaranty price target raised to $40 from $33 at UBS
UBS analyst Brian Meredith raised his price target on Assured Guaranty to $40 from $33 based on its acquisition of MBIA U.K., which should close in January. The analyst sees book value accretion as well as earnings accretion. He also said the election results could lead to increased infrastructure spending and higher interest rates. Meredith reiterated his Buy rating on Assured Guaranty shares.
02/28/17
KBWI
02/28/17
DOWNGRADE
Target $42
KBWI
Market Perform
Assured Guaranty downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Charles Tyson downgraded Assured Guaranty to Market Perform citing valuation but raised his price target for the shares to $42 from $39.
AMBC Ambac Financial
$16.92

0.32 (1.93%)

03/01/17
BTIG
03/01/17
UPGRADE
BTIG
Buy
Ambac Financial upgraded to Buy from Neutral at BTIG
05/12/17
MKMP
05/12/17
UPGRADE
MKMP
Neutral
Ambac Financial upgraded to Neutral from Sell at MKM Partners
12/19/16
MKMP
12/19/16
DOWNGRADE
Target $10
MKMP
Sell
Ambac Financial downgraded to Sell at MKM Partners
As previously reported, MKM Partners downgraded Ambac Financial to Sell from Neutral and initiated a price target of $10. Last Friday, Ambac's Wisconsin regulator updated the Rehabilitation Court on its status saying "At the present time, absent further actions, Ambac has insufficient capital to demonstrate that a "durable" exit can be achieved to the satisfaction of the Rehabilitator." Analyst Harry Fong said he continues to have difficulty assessing the appropriate value for Ambac and values at a 70% discount to its trailing ABV, or $10.
DK Delek US
$26.12

-0.35 (-1.32%)

07/25/17
WOLF
07/25/17
UPGRADE
WOLF
Outperform
Delek US upgraded to Outperform from Peer Perform at Wolfe (pre-open)
07/11/17
JPMS
07/11/17
INITIATION
Target $28
JPMS
Neutral
Delek US reinstated with a Neutral at JPMorgan
JPMorgan analyst Phil Gresh reinstated Delek US Holdings with a Neutral rating and $28 price target.
07/05/17
07/05/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pandora (P) resumed with an Overweight at Morgan Stanley. 2. Two Harbors (TWO) reinstated with an Outperform at Credit Suisse. 3. Alcentra Capital (ABDC) initiated with a Buy at DA Davidson. 4. Alon USA Partners (ALDW) reinstated with an Equal Weight at Barclays. 5. Delek US (DK) and Delek Logistics (DKL) were reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/14/17
SBSH
07/14/17
DOWNGRADE
Target $29
SBSH
Neutral
Delek US downgraded to Neutral from Buy at Citi
Citi analyst Faisel Khan downgraded Delek US Holdings to Neutral with an unchanged price target of $29.
HFC HollyFrontier
$35.42

-0.43 (-1.20%)

09/28/17
HOWW
09/28/17
UPGRADE
HOWW
Focus List
HollyFrontier upgraded to Focus List from Outperform at Scotia Howard Weil
Scotia Howard Weil analyst Blake Fernandez added HollyFrontier to the Focus List and raised its price target to $39 from $33. The analyst said the macro backdrop favors inland refiners with expanding light/sweet differentials and believes ongoing growth in Canadian production could be supportive of Canadian heavy differentials.
05/16/17
GSCO
05/16/17
DOWNGRADE
Target $73
GSCO
Neutral
Valero downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Neil Mehta downgraded Valero (VLO) to Neutral citing a more balanced risk/reward following the stock's outperformance. Further, the analyst thinks the upcoming OPEC meeting could drive further compression of the light-heavy differential. He lowered his 6-month target for the shares to $73 from $74. Mehta this morning also upgraded Delek US (DK) to Buy, kept a Buy rating on Marathon Petroleum (MRC) and a Sell rating on HollyFrontier (HFC).
08/02/17
SCOT
08/02/17
UPGRADE
SCOT
Outperform
HollyFrontier upgraded to Outperform from Sector Perform at Scotiabank
10/06/17
JPMS
10/06/17
DOWNGRADE
Target $34
JPMS
Underweight
HollyFrontier downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Phil Gresh downgraded HollyFrontier to Underweight saying valuations in Refining are "getting full" following the post-Hurricane Harvey rally. The analyst expects Brent/WTI to ultimately revert to a $3-$4 per barrel range, which he feels could weigh on HollyFrontier the most. Gresh raised his price target for the shares to $34 from $33.
MPC Marathon Petroleum
$56.02

-0.23 (-0.41%)

09/06/17
09/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HP Enterprise (HPE) downgraded to Underperform from Neutral at BofA/Merrill with analyst Wamsi Mohan citing fiscal 2018 headwinds that include increased investment, a competitive pricing environment, and higher commodity costs. 2. Marathon Petroleum (MPC) downgraded to Market Perform from Outperform at Wells Fargo with analyst Roger Read saying he now expects the incentive distribution rights buyout may be at the lower end of the prior 15-20 times range. 3. Verifone (PAY) downgraded to Neutral from Buy at Northcoast with analyst Keith Housum saying he has reduced confidence in the company's ability to grow revenues and increase profitability given the delay in reaching the point of sale market with its new Carbon and Engage platform compared to initial expectations. 4. Mallinckrodt (MNK) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying he believes yesterday's unfavorable district court ruling in Mallinckrodt's suit against Praxair (PX) has increased the risk of an Inomax generic potentially as soon as October 2018, compared to his prior expectation of 2031. 5. BHP Billiton (BHP) downgraded to Underperform from Neutral at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/17
GSCO
10/03/17
DOWNGRADE
GSCO
Neutral
Marathon Petroleum downgraded to Neutral on valuation at Goldman Sachs
As previously reported, Goldman downgraded Marathon Petroleum to Neutral from Buy. Analyst Neil Mehta said recent performance now has shares within 12% of his $63 price target and views risk/reward as more balanced.
10/03/17
GSCO
10/03/17
DOWNGRADE
GSCO
Neutral
Marathon Petroleum downgraded to Neutral from Buy at Goldman Sachs
10/06/17
EDJN
10/06/17
UPGRADE
EDJN
Buy
Marathon Petroleum upgraded to Buy from Hold at Edward Jones
PSX Phillips 66
$92.82

-0.51 (-0.55%)

09/28/17
HOWW
09/28/17
UPGRADE
HOWW
Outperform
Phillips 66 upgraded to Outperform from Sector Perform at Scotia Howard Weil
Scotia Howard Weil analyst Blake Fernandez upgraded Phillips 66 to Outperform with a $98 price target, raised from $86. The analyst said 2018 free cash flow is expanding on growth projects, such as the Gulf Coast cracker, and spending is being reduced as projects come online.
10/03/17
10/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy saying he has been pursuing expansion opportunities at an accelerating pace while maintaining its core truck and global auto business. 2. Phillips 66 (PSX) upgraded to Buy from Neutral at Goldman Sachs with analyst Neil Mehta saying he is positive on potential lower capital expenditures in 2018-2020 due to the roll off of major spending projects, sees underappreciated growth from the in-service of projects, and expects the company to benefit from a constructive outlook near-term for distillates. 3. Booz Allen (BAH) upgraded to Buy from Hold at Vertical Research. 4. Acuity Brands (AYI) upgraded to Market Perform from Underperform at JMP Securities with analyst Joseph Osha saying he believes consensus estimates are "behind the curve" and that the company should be able to protect its margins at current levels. 5. Regency Centers (REG) upgraded to Neutral from Underperform at Boenning & Scattergood. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/17
GSCO
10/03/17
UPGRADE
GSCO
Buy
Phillips 66 upgraded to Buy from Neutral at Goldman Sachs
10/03/17
10/03/17
UPGRADE

Buy
Phillips 66 upgraded to Buy at Goldman Sachs
As previously reported, Goldman upgraded Phillips 66 to Buy from Neutral with a $109 price target. Analyst Neil Mehta is positive on potential lower capital expenditures in 2018-2020 due to the roll off of major spending projects, sees underappreciated growth from the in-service of projects, and expects the company to benefit from a constructive outlook near-term for distillates.
TSO Tesoro

06/13/17
06/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Clovis (CLVS) initiated with an Outperform at Leerink. 2. Arconic (ARNC) resumed with an Equal Weight at Morgan Stanley. 3. Tesoro (TSO) reinstated with a Conviction Buy at Goldman Sachs. 4. Golden Ocean (GOGL) initiated with a Buy at Seaport Global. 5. International Seaways (INSW) initiated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/17
GSCO
06/13/17
INITIATION
Target $121
GSCO
Conviction Buy
Tesoro reinstated with a Conviction Buy at Goldman Sachs
Goldman analyst Neil Mehta reinstated Tesoro with a Conviction Buy and a $121 price target saying he sees upside from the Western Refining acquisition and sees attractive value in the midstream and marketing businesses.
06/27/17
GSCO
06/27/17
NO CHANGE
Target $121
GSCO
Conviction Buy
West Coast refining outlook not priced into Tesoro shares, say Goldman Sachs
Goldman analyst Neil Mehta expects West Coast inventories to remain relative balanced through 2017 despite the re-start of the Torrance refinery expected later this month due to strong export trends and demand levels. Mehta views Tesoro's risk/reward as attractive at current levels given the underappreciated value in its non-refining business segments, the completion of the Western Refining acquisition which will expand a Permian logistics network, provide access to Phoenix retail, and improves margins at the Mid-Continent refining segment, and capital allocation opportunities. The analyst reiterates his Conviction Buy and $121 price target on Tesoro shares.
06/05/17
DBAB
06/05/17
UPGRADE
Target $106
DBAB
Buy
Tesoro upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Ryan Todd upgraded Tesoro to Buy with an unchanged price target of $106.
VLO Valero
$77.23

-0.04 (-0.05%)

10/06/17
10/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Spirit Airlines (SAVE) downgraded to Hold from Buy at Deutsche Bank with analyst Michael Linenberg saying the company's revenue outlook "may face greater downside risk" than peers given the competitive intensity of its markets. 2. Albemarle (ALB) downgraded to Neutral from Conviction Buy at Goldman Sachs with analyst Robert Koort saying the company over the past two years has transformed from a value-oriented chemical stock into a "thematic growth engine" as investors shifted their focus to the potential of an electric vehicle revolution. 3. Cree (CREE) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 4. Valero (VLO) downgraded to Neutral from Overweight at JPMorgan with Phil Gresh citing valuation following the recent rally. 5. Walgreens Boots Alliance (WBA) downgraded to Equal Weight at Morgan Stanley with analyst Ricky Goldwasser saying he expects the company's guidance to come in below consensus estimates when it is provided later this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/17
COWN
09/28/17
NO CHANGE
Target $90
COWN
Outperform
Valero price target raised to $90 from $70 at Cowen
Cowen analyst Sam Margolin raised his price target on Valero to $90 from $70 as he sees multiple expansion due to the company's capital allocation strategy, which prioritizes dividend growth and limits capex to projects with a 25% internal rate of return hurdle. Margolin reiterated his Outperform rating on Valero shares.
09/27/17
UBSW
09/27/17
NO CHANGE
Target $80
UBSW
Neutral
Valero price target raised to $80 from $69 at UBS
UBS analyst Spiro Dounis raised his price target on Valero to $80 from $69 with the main driver the increase in the refining segment EV/EBITDA multiple. Dounis believes the company's increasingly less volatile earnings support a premium multiple. However, he maintains his Neutral rating on Valero shares due to the stock's recent strong performance.
10/06/17
JPMS
10/06/17
DOWNGRADE
Target $78
JPMS
Neutral
Valero downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Phil Gresh downgraded Valero Energy to Neutral citing valuation following the recent rally. The analyst raised his price target for the shares to $78 from $75.
WNR Western Refining

05/30/17
MSCO
05/30/17
UPGRADE
Target $110
MSCO
Overweight
Tesoro upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Benny Wong upgraded Tesoro (TSO) to Overweight and raised its price target to $110 from $100. The analyst said Tesoro's the acquisition of Western Refining (WNR) diversifies growth, expands its integrated strategy, and a potential MLP restructuring would unlock value. Further, the analyst sees upside from a potential pickup in Permian margins, strong West Coast cracks, and synergies.
04/06/17
JPMS
04/06/17
NO CHANGE
Target $97
JPMS
Overweight
Tesoro pullback a buying opportunity, says JPMorgan
JPMorgan analyst Phil Gresh recommends using the pullback in Tesoro (TSO) shares to below $80 as a buying opportunity. The analyst continues to believe that closing the Western Refining (WNR) deal will be a "key fundamental and technical catalyst" for the stock. He lowered his price target for Tesoro shares to $97 from $98 and keeps an Overweight rating on the name.
03/24/17
03/24/17
DOWNGRADE
Target $40

Neutral
Western Refining downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Edward Westlake downgraded Western Refining (WNR) to Neutral from Outperform as acquisition nears. The analyst notes that the combination of Western Refining/Tesoro (TSO) creates synergistic overlap in the South West product markets and around St. Paul Park/Mandan plus opportunities to offer full service logistics to customers in the Permian and Bakken. The analyst lowered his price target on Western Refining's shares to $40 from $48 to reflect the acquisition offer exchange rate.
03/24/17
FBCO
03/24/17
DOWNGRADE
FBCO
Neutral
Western Refining downgraded to Neutral from Outperform at Credit Suisse
GPRE Green Plains
$20.05

-0.5 (-2.43%)

04/26/17
04/26/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Market Perform at Raymond James. 2. Electronic Arts (EA), Take-Two (TTWO), and Activision Blizzard (ATVI) were resumed with an Overweight at Pacific Crest, while Zynga (ZNGA) resumed with a Sector Weight at Pacific Crest. 3. Green Plains (GPRE) initiated with an Outperform at BMO Capital. 4. Chesapeake Utilities (CPK) initiated with a Sector Perform at RBC Capital. 5. Callon Petroleum (CPE) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/26/17
BMOC
04/26/17
INITIATION
Target $30
BMOC
Outperform
Green Plains initiated with an Outperform at BMO Capital
BMO Capital analyst Kenneth Zaslow initiated Green Plains with an Outperform and a $30 price target.
11/25/16
PIPR
11/25/16
NO CHANGE
PIPR
Piper views EPA ruling as positive for Green Plains, Renewable Energy
The Environmental Protection Agency on Wednesday released the final 2017 Renewable Volume Obligations under the Renewable Fuel Standard, Piper Jaffray analyst Brett Wong tells investors in a research note. The ruling shows support for biofuel growth across all categories, including conventional corn ethanol, Wong contends. He believes Green Plains (GPRE) and Renewable Energy (REGI) are poised to benefit on the 2017 final ruling.
09/14/17
CHLM
09/14/17
INITIATION
Target $29
CHLM
Buy
Green Plains initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Eric Stine started Green Plains with a Buy rating and $29 price target saying that combined with significant and stable non-ethanol businesses, he sees it trading 50-100% higher.
PEIX Pacific Ethanol
$5.43

-0.275 (-4.82%)

12/12/16
CHLM
12/12/16
NO CHANGE
Target $14
CHLM
Buy
Pacific Ethanol price target raised to $14 from $10 at Craig-Hallum
Craig-Hallum analyst Eric Stine said Pacific Ethanol's debt refinancing removes an overhang and provides a meaningful catalyst for the stock. The analyst, who views the refinancing as having been done at favorable terms, raised his price target on the stock to $14 from $10 and keeps a Buy rating on the shares.
REGI Renewable Energy
$11.60

-0.5 (-4.13%)

05/05/17
ADAM
05/05/17
UPGRADE
Target $16
ADAM
Buy
Renewable Energy upgraded to Buy from Hold at Canaccord
Canaccord analyst John Quealy upgraded Renewable Energy to Buy from Hold and increased its price target to $16 from $11. After three years, the analyst now views risk/reward as compelling given the combination of a more favorable biodiesel macros, an enhanced platform, and solid management execution.
11/03/16
PIPR
11/03/16
DOWNGRADE
PIPR
Neutral
Renewable Energy downgraded to Neutral from Overweight at Piper Jaffray
DAR Darling Ingredients
$16.38

-1.51 (-8.44%)

08/14/17
JPMS
08/14/17
NO CHANGE
Target $19
JPMS
Overweight
Darling Ingredients price target raised to $19 from $17 at JPMorgan
JPMorgan analyst Thomas Palmer raised his price target for Darling Ingredients to $19 following last week's Q2 results. The company's Diamond Green Diesel joint venture is beginning to demonstrate the long-term earnings ramp management has long spoke about, Palmer tells investors in a research note. The analyst reiterates an Overweight rating on the shares.
09/26/17
BARD
09/26/17
NO CHANGE
Target $20
BARD
Outperform
Darling Ingredients remains a top pick, says Baird
Baird analyst Ben Kallo said key drivers are in place to support substantial EBITDA growth in 2018 and beyond for Darling Ingredients. The analyst also cited key regulatory drivers as well and said others could fall into place, which will boost the company's growth profile. Kallo reiterated his Outperform rating and $20 price target on Darling Ingredients and said it remains a top pick.
03/22/17
BARD
03/22/17
INITIATION
Target $19
BARD
Outperform
Darling Ingredients initiated with an Outperform at Baird
Baird analyst Ben Kallo initiated Darling with an Outperform and a $19 price target.
10/06/17
JPMS
10/06/17
DOWNGRADE
Target $18
JPMS
Neutral
Darling Ingredients downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Thomas Palmer downgraded Darling Ingredients to Neutral citing valuation with the shares up 39% year-to-date as well as regulatory risk. The U.S. Commerce Department's preliminary duties on biodiesel imports from Argentina and Indonesia were greater than anticipated and the EPA's decision to potentially reduce biomass-based diesel mandates for 2018 and 2019 could also weigh on pricing, Palmer tells investors in a research note. The analyst lowered his price atrget for the shares to $18 from $19.
CMCSA Comcast
$38.01

-0.34 (-0.89%)

09/12/17
09/12/17
UPGRADE

Buy
Comcast upgraded to Buy on valuation at MoffettNathanson
As previously reported, MoffettNathanson upgraded Comcast to Buy from Neutral with a $45 price target. Analyst Craig Moffett said Comcast shares cheap following management comments on Q3 subscriber loses and the resulting stock selloff is overdone.
09/12/17
09/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comerica (CMA) upgraded to Overweight from Neutral at Piper Jaffray with analyst Brett Rabatin saying the bank's mid-quarter update is better than expected. 2. Alcoa (AA) upgraded to Buy from Hold at Deutsche Bank with analyst Jorge Beristain basing the upgrade on the firm's commodity team raising its 2018 aluminum price forecast by 12% to $2,072 per ton. 3. Kroger (KR) upgraded to Buy from Hold at Pivotal Research with analyst Ajay Jain saying continued weakness in investor sentiment following Kroger's latest results presents a near-term buying opportunity. 4. Comcast (CMCSA) upgraded to Buy from Neutral at MoffettNathanson with analyst Craig Moffett saying Comcast shares cheap following management comments on third quarter subscriber loses and the resulting stock selloff is overdone. 5. Inovalon (INOV) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Ricky Goldwasser saying that the company's presentation at the firm's healthcare conference provided a line of sight to organic earnings acceleration in the second half of the year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/17
STFL
10/06/17
NO CHANGE
Target $200
STFL
Buy
Netflix 'still the best value' for consumers despite price hike, says Stifel
After Netflix (NFLX) disclosed it is raising subscription prices for the Standard and Premium tiers in the U.S., Stifel analyst Scott Devitt said he expects "similar round number increases" in a number of other markets, noting that the company has also confirmed increases for its top two U.K. plans. The analyst, who noted that Hulu's ad-free option and HBO Now (TWX) remain as expensive or more expensive than Netflix, said its streaming service is "still the best value on the consumer Internet." Devitt keeps a Buy rating and $200 price target on Netflix shares.
09/29/17
JPMS
09/29/17
NO CHANGE
JPMS
Expert sees positive settlements for TiVo, says JPMorgan
JP Morgan analyst Sterling Auty hosted Bloomberg Intelligence Litigation Analyst Matt Larson to discuss TiVo's (TIVO) ITC and District Court cases with Comcast (CMCSA, CMCSK) and Hulu. Larson said he believes settlement is the most likely outcome in both cases, which Auty sees as a positive for TiVo. A positive resolution could have "material upside" for TiVo's shares, as it bolsters the case for TiVo driving earnings to the $3 per share level, Auty added. JP Morgan kept an Overweight rating and $34 price target on TiVo shares.

TODAY'S FREE FLY STORIES

SYNT

Syntel

$24.30

5.2 (27.23%)

20:37
10/17/17
10/17
20:37
10/17/17
20:37
Upgrade
Syntel rating change at William Blair »

Syntel upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 14

    Dec

QD

Qudian

20:35
10/17/17
10/17
20:35
10/17/17
20:35
Syndicate
Qudian 37.5M share IPO priced at $24.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ABT

Abbott

$55.06

0.43 (0.79%)

, USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

20:25
10/17/17
10/17
20:25
10/17/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$55.06

0.43 (0.79%)

USB

U.S. Bancorp

$53.88

-0.38 (-0.70%)

SVU

Supervalu

$19.38

0.57 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 17

    Jan

UNH

UnitedHealth

$203.89

10.69 (5.53%)

19:58
10/17/17
10/17
19:58
10/17/17
19:58
Recommendations
UnitedHealth analyst commentary at Piper Jaffray »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

19:25
10/17/17
10/17
19:25
10/17/17
19:25
Conference/Events
The Heritage Foundation hosts President Trump »

President Trump speaks at…

SINA

Sina

$114.26

-0.73 (-0.63%)

19:18
10/17/17
10/17
19:18
10/17/17
19:18
Hot Stocks
Aristeia: Sina claims 'inaccurate' and 'misleading' »

Aristeia Capital, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

CLDR

Cloudera

$15.51

0.13 (0.85%)

, HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

18:57
10/17/17
10/17
18:57
10/17/17
18:57
Hot Stocks
Cloudera, Hitachi form strategic partnership »

Cloudera (CLDR) announced…

CLDR

Cloudera

$15.51

0.13 (0.85%)

HTHIY

Hitachi

$75.56

-0.49 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$65.15

-1.15 (-1.73%)

18:35
10/17/17
10/17
18:35
10/17/17
18:35
Earnings
Pinnacle Financial reports Q3 adjusted EPS 90c, consensus 74c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial sees FY17 loans & deposits growth mid to high single digits »

Sees FY17 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

EXXI

Energy XXI

$8.59

-0.41 (-4.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Energy XXI provides operational update on Hurricane Nate impact »

Energy XXI provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$18.95

-0.3 (-1.56%)

18:07
10/17/17
10/17
18:07
10/17/17
18:07
Hot Stocks
Fulton Financial cuts Q4 net interest margin view to up 2-6 bp from 3-9 »

Cuts Q4 non-interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 01

    Nov

  • 02

    Nov

HGV

Hilton Grand Vacations

$39.83

0.05 (0.13%)

17:45
10/17/17
10/17
17:45
10/17/17
17:45
Hot Stocks
Hilton Grand Vacations acquires Sunrise Lodge, terms not disclosed »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

PRGX

PRGX Global

$6.80

0.05 (0.74%)

, KR

Kroger

$20.48

0.04 (0.20%)

17:42
10/17/17
10/17
17:42
10/17/17
17:42
Hot Stocks
PRGX Global signs multi-year technology services contract with Kroger »

PRGX Global (PRGX) signed…

PRGX

PRGX Global

$6.80

0.05 (0.74%)

KR

Kroger

$20.48

0.04 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 14

    Dec

UBFO

United Security Bank

$9.50

-0.05 (-0.52%)

17:38
10/17/17
10/17
17:38
10/17/17
17:38
Earnings
United Security Bank reports Q3 EPS 16c versus 12c in year-ago period »

Reports Q3 NII $8.2M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

, XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
Xenith Bankshares merger into Union Bankshares receives regulatory approval »

Union Bankshares (UBSH)…

UBSH

Union Bankshares

$35.32

-0.18 (-0.51%)

XBKS

Xenith Bankshares

$32.77

-0.07 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:35
10/17/17
10/17
17:35
10/17/17
17:35
Hot Stocks
OMA Airports reports Q3 terminal passenger traffic up 1.3% »

Aeronautical revenues per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$146.54

-0.29 (-0.20%)

17:34
10/17/17
10/17
17:34
10/17/17
17:34
Earnings
IBM sees $2.8B-$2.9B increase in Q4 sales from Q3 »

Sees $300M-$400M boost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

OMAB

OMA Airports

$41.34

0.28 (0.68%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Earnings
OMA Airports reports Q3 EPS 66c, consensus 70c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:33
10/17/17
10/17
17:33
10/17/17
17:33
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

, IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: IBM…

IBM

IBM

$146.54

-0.29 (-0.20%)

IBKR

Interactive Brokers

$47.40

-0.32 (-0.67%)

SSKN

STRATA Skin Sciences

$1.75

-0.04 (-2.23%)

HCLP

Hi-Crush Partners

$8.95

0.25 (2.87%)

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

NAVI

Navient

$12.20

0.47 (4.01%)

CREE

Cree

$29.34

0.06 (0.20%)

AKTX

Akari Therapeutics

$6.40

-0.08 (-1.23%)

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

FOGO

Fogo De Chao

$12.05

0.1 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 22

    Oct

  • 01

    Nov

  • 15

    Nov

  • 18

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:32
10/17/17
10/17
17:32
10/17/17
17:32
Hot Stocks
IBM sees increase in gross margin of 2.5 points from Q3 to Q4 »

Says not yet feeling full…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

PAYX

Paychex

$62.90

-0.55 (-0.87%)

17:31
10/17/17
10/17
17:31
10/17/17
17:31
Syndicate
Breaking Syndicate news story on Paychex »

Paychex files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

VZ

Verizon

$48.40

0.31 (0.64%)

17:24
10/17/17
10/17
17:24
10/17/17
17:24
Hot Stocks
FCC settles New York City E-rate investigation with Verizon »

The Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

17:20
10/17/17
10/17
17:20
10/17/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Select Comfort »

Select Comfort expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$146.54

-0.29 (-0.20%)

17:17
10/17/17
10/17
17:17
10/17/17
17:17
Hot Stocks
IBM: Global business services signings up for 3rd consecutive quarter »

Says cognitive solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.